Sensible Biotechnologies
Unlocking the next generation of mRNA medicines
About
The future of mRNA therapeutics is hampered by manufacturing challenges and unless solved, its exciting potential may never be realised. Sensible enables the next generation of mRNA medicines by turning living cells into factories producing abundant, highly stable and non-immunogenic mRNA in a scalable and cost-effective way.
Topics
- Location
- Oxford, United Kingdom
- Team size
- 55 employees
- YC batch
- Summer 2021
- Status
- Active
- Stage
- Early stage
